Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 1
2022 4
2024 1
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Approach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providers.
Sherman MA, Nicolai R, Datyner EK, Rosina S, Hamilton A, Ardalan K, Bader-Meunier B, Brown AG, Jansen MHA, Kim S, Lang B, Campanilho-Marques R, McCann LJ, Sanner H, Veldkamp SR, Wilkinson MGL, Yi BY, Kim H, Tarvin SE, Papadopoulou C; CARRA JDM Therapeutics Workgroup and the PReS JDM Working Party. Sherman MA, et al. Among authors: veldkamp sr. Rheumatology (Oxford). 2025 Aug 1;64(8):4732-4737. doi: 10.1093/rheumatology/keaf086. Rheumatology (Oxford). 2025. PMID: 39928372 Free PMC article.
Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacy.
Veldkamp SR, Reugebrink M, Evers SW, Moreau TRJ, Bondet V, Armbrust W, van den Berg JM, Hissink Muller PCE, Kamphuis S, Schatorjé E, Delemarre EM, van der Kooi AJ, Bader-Meunier B, Duffy D, Rodero MP, Raaphorst J, van Royen-Kerkhof A, Jansen MHA, van Wijk F. Veldkamp SR, et al. Rheumatology (Oxford). 2025 Sep 1;64(9):5132-5141. doi: 10.1093/rheumatology/keaf227. Rheumatology (Oxford). 2025. PMID: 40372702 Free PMC article.
Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia.
Dekker L, Calkoen FG, Jiang Y, Blok H, Veldkamp SR, De Koning C, Spoon M, Admiraal R, Hoogerbrugge P, Vormoor B, Vormoor HJ, Visscher H, Bierings M, Van Der Vlugt M, Van Tinteren H, Nijstad AL, Huitema ADR, Van Der Elst KCM, Pieters R, Lindemans CA, Nierkens S. Dekker L, et al. Among authors: veldkamp sr. Blood Adv. 2022 Apr 12;6(7):1969-1976. doi: 10.1182/bloodadvances.2021006700. Blood Adv. 2022. PMID: 35134115 Free PMC article.
Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response.
Lerkvaleekul B, Veldkamp SR, van der Wal MM, Schatorjé EJH, Kamphuis SSM, van den Berg JM, Hissink Muller PCE, Armbrust W, Vastert SJ, Wienke J, Jansen MHA, van Royen-Kerkhof A, van Wijk F. Lerkvaleekul B, et al. Among authors: veldkamp sr. Rheumatology (Oxford). 2022 May 5;61(5):2144-2155. doi: 10.1093/rheumatology/keab601. Rheumatology (Oxford). 2022. PMID: 34387304 Free PMC article.
MRP8/14 and neutrophil elastase for predicting treatment response and occurrence of flare in patients with juvenile idiopathic arthritis.
Barendregt AM, Veldkamp SR, Hissink Muller PCE, van de Geer A, Aarts C, van Gulik EC, Schilham MW, Kessel C, Keizer MP, Hemke R, Nassar-Sheikh Rashid A, Dolman KM, Schonenberg-Meinema D, Ten Cate R, van den Berg JM, Maas M, Kuijpers TW. Barendregt AM, et al. Among authors: veldkamp sr. Rheumatology (Oxford). 2020 Sep 1;59(9):2392-2401. doi: 10.1093/rheumatology/kez590. Rheumatology (Oxford). 2020. PMID: 31904851 Free PMC article.
11 results